Cargando…
C-42 | Insights Regarding Adverse Outcomes of Pulmonary Embolism in Adult Hospitalizations With COVID-19 Co-Existing With Atrial Fibrillation / Atrial Flutter: From National Inpatient Sample Database 2020
Autores principales: | Gajjar, Rohan A., Teaima, Taha, Aziz, Imran, Battikh, Naim, Shoura, Sami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192974/ http://dx.doi.org/10.1016/j.jscai.2023.100830 |
Ejemplares similares
-
PO-04-156 INSIGHTS REGARDING OUTCOMES FOR COVID-19 HOSPITALIZATIONS WITH ADULT CONGENITAL HEART DISEASE (ACHD)
por: Gajjar, Rohan, et al.
Publicado: (2023) -
Ehrlichiosis-Induced Atrial Flutter: An Unusual Cause of Atrial Flutter
por: Kunnumpurath, Anthony, et al.
Publicado: (2020) -
Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006) -
Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
por: Wolbrette, Deborah, et al.
Publicado: (2010) -
IMPACT OF ATRIAL FIBRILLATION ON COVID-19 PNEUMONIA HOSPITALIZATIONS: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE 2020
por: Kodali, Mouna, et al.
Publicado: (2023)